Ignite Creation Date:
2024-05-05 @ 6:47 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00547781
Status:
COMPLETED
Last Update Posted:
2012-04-02
First Post:
2007-10-22
Brief Title:
Implantation Failure and PGD
Sponsor:
Instituto Valenciano de Infertilidad IVI VALENCIA
Organization:
Instituto Valenciano de Infertilidad IVI VALENCIA
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to performed a randomized controlled trial to evaluate the usefulness of preimplantation genetic diagnosis PGD in patients with repetitive implantation failure Patients will be prospectively randomized in two groups standard IVF with blastocyst transfer on day-5 and transfer day-5 after PGD for aneuploidy screening for chromosomes 13 15 16 18 21 22 X and Y The end points of the study are Cancellation rate implantation rate and ongoing implantation rate Inclusion criteria are patients with 2 previous IVF failure without clinical or biochemical pregnancy with transfer of at least 2 good quality embryos per transfer Exclusion criteria will be uterine abnormalities abnormal karyotypes abnormal result in thrombophilia screening and low responder patients less than 4 expected oocytes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None